CRP and cancer: CRP has been widely used as a robust inflammatory biomarker for many health conditions in both clinical and research settings, and several studies have shown a positive correlation between plasma CRP levels and pain intensity in cancer patients [17–19]; however, these results were from cross-sectional studies, which were often limited by uncertain temporal relationships or from the univariate analysis without adjustment for confounding variables [20, 21].